Ronnie Aronson
LMC Diabetes & Endocrinology (Canada)(CA)
Publications by Year
Research Areas
Diabetes Management and Research, Diabetes Treatment and Management, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer, Diabetes and associated disorders
Most-Cited Works
- → Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections(2017)599 cited
- → Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial(2019)595 cited
- → Triiodothyronine Augmentation in the Treatment of Refractory Depression(1996)489 cited
- → Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes(2020)352 cited
- → Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin(2013)283 cited
- → Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study(2016)265 cited
- → Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial(2016)259 cited
- → Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus(2013)254 cited
- → Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine(2013)250 cited
- → Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial(2014)228 cited